Financhill
Back

Verve Therapeutics Vs. Immuneering Industry Stock Comparison

Sell
25

VERV
Verve Therapeutics

Last Price:
4.85
Seasonality Move:
-11.16%
Sell
42

IMRX
Immuneering

Last Price:
2.10
Seasonality Move:
-27.69%
Sell
25
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics a Buy, Sell or Hold?

  • The current Verve Therapeutics [VERV] share price is $4.85. The Score for VERV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Immuneering (IMRX) is a Sell

Is Immuneering a Buy, Sell or Hold?

  • The current Immuneering [IMRX] share price is $2.10. The Score for IMRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • IMRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VERV Stock Price Chart

What is Verve Therapeutics's stock price today?

  • The Verve Therapeutics share price today is $4.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.

IMRX Stock Price Chart

What is Immuneering's stock price today?

  • The Immuneering share price today is $2.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMRX is experiencing selling pressure, which indicates risk of future bearish movement.

VERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.23 Sell
Relative Strength Index (14 RSI): 40.26 Sell
Chaikin Money Flow: 1039980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.04 - 6.28) Sell
Bollinger Bands (100): (4.83 - 6.53) Sell

IMRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 54.77 Buy
Chaikin Money Flow: -197229 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.84 - 2.1) Buy
Bollinger Bands (100): (1.13 - 2.29) Buy

VERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.91 Sell
20-day SMA: 5.65 Sell
50-day SMA: 5.36 Sell
200-day SMA: 7.32 Sell
8-day EMA: 4.99 Sell
20-day EMA: 5.35 Sell
50-day EMA: 5.47 Sell
200-day EMA: 7.4 Sell

IMRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.94 Buy
20-day SMA: 1.93 Buy
50-day SMA: 2.22 Sell
200-day SMA: 2.26 Sell
8-day EMA: 2 Buy
20-day EMA: 1.98 Buy
50-day EMA: 1.97 Buy
200-day EMA: 2.71 Sell

Verve Therapeutics Earnings Growth & VERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.

Immuneering Earnings Growth & IMRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.22 per share.

Verve Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Immuneering Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):